A clinical study on the effects of dexmedetomidine and propofol on erythrocyte deformability during anaesthesia
Purpose: To investigate the clinical effects of dexmedetomidine and propofol on erythrocyte deformability (ED) in patients undergoing laparoscopic cholecystectomy.
Methods: A total of 522 patients undergoing gallbladder removal surgery were randomly divided into groups A (dexmedetomidine group), B (propofol group), and C (control). Erythrocyte suspensions were prepared from each group. Then, erythrocyte deformability index (EI) was measured in terms of RBC deformability. Moreover, endothelial nitric oxide synthase (eNOS) activity, and concentrations of nitric oxide (NO) were determined. Patients in the three groups received the same anaesthesia induction and maintenance, and their EI and Hct values were assayed before anaesthesia (T0) and post-surgery (T1). The activity of eNOS in each group was assayed using immunofluorescence microscopy and western blotting analysis.
Results: There were higher levels of EI and NO, and higher eNOS activity in erythrocytes in the dexmedetomidine group than in the propofol and ginsenoside groups (p < 0.05). Post-naethesia EI (T0) values were higher in propofol and control groups than in dexmedetomidine group (p < 0.05). The protein expression of eNOS was higher in dexmedetomidine group, as was evident from immunofluorescence and western blotting analyses.
Conclusion: Perioperative use of dexmedetomidine during anaesthesia increases RBC deformability in vitro and directly upregulates eNOS activity in erythrocytes.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.